Matthew Henriksson
PersonHeard in 1 episode across 1 show since Oct 2026
Matthew Henriksson is a CFA and senior medical technology analyst at Bloomberg Intelligence, where he covers companies in areas including cardiology, orthopedics, and diabetes. He is also a co-host of Bloomberg Intelligence’s Vanguards of Healthcare podcast.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
Email alert
Email me when Matthew Henriksson comes up on a podcast
One email a week at most, with the new episodes that mention Matthew Henriksson. Free, no account needed, unsubscribe in one click.
What Matthew Henriksson has said on podcasts
6 statements
Abbott is spinning off nutrition because it is the portfolio's weak segment.
“they're finally spinning off their nutrition segment because that's probably the black sheep of the overall portfolio for them”
Open the episode · SpaceX, Tesla Boards Study Possible $3.5 Trillion MergerListen at 10:09
Abbott's spin-off will let it focus on medical-device growth drivers.
“that allows them to focus on their kind of key growth drivers, which is in the medical device space”
Open the episode · SpaceX, Tesla Boards Study Possible $3.5 Trillion MergerListen at 10:18
Abbott's continuous glucose monitor growth is slowing to 7% this year.
“You're seeing that growth decelerate from 20% in 2024, 16% last year to 7% this year.”
Open the episode · SpaceX, Tesla Boards Study Possible $3.5 Trillion MergerListen at 12:14
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Matthew Henriksson, newest first